Cutaneous T-cell Lymphoma - 27 Studies Found
| Completed |
: A Study for Patients With Relapsed Cutaneous T-Cell Lymphoma : Cutaneous T-Cell Lymphoma : 2008-08-29 : Drug: Enzastaurin 1125 mg loading dose then 500 mg, oral, daily, until disease progression |
| Completed |
: Tazarotene 0.1% Cream For the Treatment of Cutaneous T-Cell Lymphoma: A Prospective Study : Cutaneous T-Cell Lymphoma : 2008-10-22 : Drug: Tazarotene Topical 0.1 cream - apply to lesions on alternate days and at 2 week interval increase |
| Recruiting |
: Poly ICLC, Radiation, and Romidepsin for Advanced Cutaneous T Cell Lymphoma : Cutaneous T-cell Lymphoma : 2014-02-11 :
|
| Withdrawn |
: Therapeutic Efficacy of Topical Sirolimus in Early Stage Cutaneous T-cell Lymphoma (CTCL) : Cutaneous T-cell Lymphoma (CTCL) : 2013-04-24 : Drug: Sirolimus 0.1% Ointment Sirolimus 0.1% ointment will be applied topically to all affected areas of |
| Active, not recruiting |
: Topical Resiquimod for the Treatment of Early Stage Cutaneous T Cell Lymphoma (CTCL) : Cutaneous T Cell Lymphoma : 2012-07-15 :
|
| Completed |
: Study of Oral Bexarotene in Combination With Photopheresis for Treatment of Cutaneous T-Cell Lymphoma : Cutaneous T-Cell Lymphoma : 2006-03-23 :
|
| Completed |
: A Single Agent Phase II Study of Romidepsin (Depsipeptide, FK228) in the Treatment of Cutaneous T-cell Lymphoma (CTCL) : Cutaneous T-cell Lymphoma : 2005-03-24 : Drug: romidepsin (depsipeptide, FK228) Study patients received romidepsin at a dose of 14 mg/m^2 intrave |
| Recruiting |
: Study of IPH4102 in Patients With Relapsed/Refractory Cutaneous T-cell Lymphomas (CTCL) : Cutaneous T-Cell Lymphoma : 2015-10-29 : Biological: IPH4102 |
| Recruiting |
: Study on Therapy With Dimethylfumarate (DMF) in Patients With Cutaneous T Cell Lymphoma (CTCL) : Cutaneous T Cell Lymphoma : 2015-09-06 : Drug: dimethylfumarate dose escalation from 30 mg/d to 720 mg/d over 9 weeks following a preset design i |
| Completed |
: Study Evaluating Two Dose Levels of Targretin Capsules in Patients With Refractory Cutaneous T-cell Lymphoma (CTCL) : Refractory Cutaneous T-cell Lymphoma : 2009-11-03 :
|